Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma

Kosaku Uchida, Masashi Kondo, Shin Takeda, Hirotaka Osada, Toshitada Takahashi, Akimasa Nakao, Takashi Takahashi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The insulin-like growth factor 2 (IGF2) gene is regulated in a complex manner, involving developmentally regulated use of four different promoters as well as transcriptional repression of the maternal allele due to genomic imprinting. It has been well documented that the liver is an exceptional organ in which overall transcription from the four IGF2 promoters is markedly imbalanced towards preferential paternal expression only in fetal life, this being relaxed during the postnatal period, resulting in biallelic expression thereafter. We previously reported a marked allelic-expression imbalance in the overall transcription of IGF2 in hepatocellular carcinoma (HCC), leading to preferential expression nonrandomly from the paternal allele. The study presented here, using 18 HCC specimens taken directly from patients, showed that this molecular change often reflects promoter switching from the adult P1 promoter to the fetal P2, P3, and P4 promoters. Interestingly, however, we found that restoration of allele-specific expression of the P1 promoter nonrandomly from the paternal allele was also frequent in HCC, suggesting retention of an imprint for paternal expression from the P1 promoter of IGF2 in adult normal liver and altered availability of its modifying factor or factors in HCC. Further studies of the molecular mechanisms involved in the fluctuation of promoter usage and genomic imprinting of IGF2 are warranted to gain an insight into the biology of the liver in terms of development and oncogenesis.

Original languageEnglish
Pages (from-to)193-198
Number of pages6
JournalMolecular Carcinogenesis
Volume18
Issue number4
DOIs
Publication statusPublished - 01-04-1997

Fingerprint

Somatomedins
Hepatocellular Carcinoma
Alleles
Genomic Imprinting
Genes
Liver
Allelic Imbalance
Carcinogenesis
Mothers

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research

Cite this

Uchida, Kosaku ; Kondo, Masashi ; Takeda, Shin ; Osada, Hirotaka ; Takahashi, Toshitada ; Nakao, Akimasa ; Takahashi, Takashi. / Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. In: Molecular Carcinogenesis. 1997 ; Vol. 18, No. 4. pp. 193-198.
@article{c5b06d0892574509b0bb32d0f71b0ebf,
title = "Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma",
abstract = "The insulin-like growth factor 2 (IGF2) gene is regulated in a complex manner, involving developmentally regulated use of four different promoters as well as transcriptional repression of the maternal allele due to genomic imprinting. It has been well documented that the liver is an exceptional organ in which overall transcription from the four IGF2 promoters is markedly imbalanced towards preferential paternal expression only in fetal life, this being relaxed during the postnatal period, resulting in biallelic expression thereafter. We previously reported a marked allelic-expression imbalance in the overall transcription of IGF2 in hepatocellular carcinoma (HCC), leading to preferential expression nonrandomly from the paternal allele. The study presented here, using 18 HCC specimens taken directly from patients, showed that this molecular change often reflects promoter switching from the adult P1 promoter to the fetal P2, P3, and P4 promoters. Interestingly, however, we found that restoration of allele-specific expression of the P1 promoter nonrandomly from the paternal allele was also frequent in HCC, suggesting retention of an imprint for paternal expression from the P1 promoter of IGF2 in adult normal liver and altered availability of its modifying factor or factors in HCC. Further studies of the molecular mechanisms involved in the fluctuation of promoter usage and genomic imprinting of IGF2 are warranted to gain an insight into the biology of the liver in terms of development and oncogenesis.",
author = "Kosaku Uchida and Masashi Kondo and Shin Takeda and Hirotaka Osada and Toshitada Takahashi and Akimasa Nakao and Takashi Takahashi",
year = "1997",
month = "4",
day = "1",
doi = "10.1002/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.0.CO;2-F",
language = "English",
volume = "18",
pages = "193--198",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "4",

}

Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma. / Uchida, Kosaku; Kondo, Masashi; Takeda, Shin; Osada, Hirotaka; Takahashi, Toshitada; Nakao, Akimasa; Takahashi, Takashi.

In: Molecular Carcinogenesis, Vol. 18, No. 4, 01.04.1997, p. 193-198.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma

AU - Uchida, Kosaku

AU - Kondo, Masashi

AU - Takeda, Shin

AU - Osada, Hirotaka

AU - Takahashi, Toshitada

AU - Nakao, Akimasa

AU - Takahashi, Takashi

PY - 1997/4/1

Y1 - 1997/4/1

N2 - The insulin-like growth factor 2 (IGF2) gene is regulated in a complex manner, involving developmentally regulated use of four different promoters as well as transcriptional repression of the maternal allele due to genomic imprinting. It has been well documented that the liver is an exceptional organ in which overall transcription from the four IGF2 promoters is markedly imbalanced towards preferential paternal expression only in fetal life, this being relaxed during the postnatal period, resulting in biallelic expression thereafter. We previously reported a marked allelic-expression imbalance in the overall transcription of IGF2 in hepatocellular carcinoma (HCC), leading to preferential expression nonrandomly from the paternal allele. The study presented here, using 18 HCC specimens taken directly from patients, showed that this molecular change often reflects promoter switching from the adult P1 promoter to the fetal P2, P3, and P4 promoters. Interestingly, however, we found that restoration of allele-specific expression of the P1 promoter nonrandomly from the paternal allele was also frequent in HCC, suggesting retention of an imprint for paternal expression from the P1 promoter of IGF2 in adult normal liver and altered availability of its modifying factor or factors in HCC. Further studies of the molecular mechanisms involved in the fluctuation of promoter usage and genomic imprinting of IGF2 are warranted to gain an insight into the biology of the liver in terms of development and oncogenesis.

AB - The insulin-like growth factor 2 (IGF2) gene is regulated in a complex manner, involving developmentally regulated use of four different promoters as well as transcriptional repression of the maternal allele due to genomic imprinting. It has been well documented that the liver is an exceptional organ in which overall transcription from the four IGF2 promoters is markedly imbalanced towards preferential paternal expression only in fetal life, this being relaxed during the postnatal period, resulting in biallelic expression thereafter. We previously reported a marked allelic-expression imbalance in the overall transcription of IGF2 in hepatocellular carcinoma (HCC), leading to preferential expression nonrandomly from the paternal allele. The study presented here, using 18 HCC specimens taken directly from patients, showed that this molecular change often reflects promoter switching from the adult P1 promoter to the fetal P2, P3, and P4 promoters. Interestingly, however, we found that restoration of allele-specific expression of the P1 promoter nonrandomly from the paternal allele was also frequent in HCC, suggesting retention of an imprint for paternal expression from the P1 promoter of IGF2 in adult normal liver and altered availability of its modifying factor or factors in HCC. Further studies of the molecular mechanisms involved in the fluctuation of promoter usage and genomic imprinting of IGF2 are warranted to gain an insight into the biology of the liver in terms of development and oncogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0030989158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030989158&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.0.CO;2-F

DO - 10.1002/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.0.CO;2-F

M3 - Article

VL - 18

SP - 193

EP - 198

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 4

ER -